Previous Article | Next Article 
J Virol, March 1998, p. 2177-2182, Vol. 72, No. 3
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
The Nucleotide Sequence and Spliced pol
mRNA Levels of the Nonprimate Spumavirus Bovine Foamy
Virus
Donald L.
Holzschu,1,
Mari A.
Delaney,1
Randall W.
Renshaw,2 and
James W.
Casey1,*
Department of Microbiology and
Immunology1 and
Veterinary Diagnostic
Laboratory,2 College of Veterinary Medicine,
Cornell University, Ithaca, New York 14853
Received 24 March 1997/Accepted 9 December 1997
 |
ABSTRACT |
We have determined the complete nucleotide sequence of a
replication-competent clone of bovine foamy virus (BFV) and have quantitated the amount of splice pol mRNA processed early
in infection. The 544-amino-acid Gag protein precursor has little
sequence similarity with its primate foamy virus homologs, but the
putative nucleocapsid (NC) protein, like the primate NCs, contains the
three glycine-arginine-rich regions that are postulated to bind genomic
RNA during virion assembly. The BFV gag and pol
open reading frames overlap, with pro and pol
in the same translational frame. As with the human foamy virus (HFV)
and feline foamy virus, we have detected a spliced pol mRNA
by PCR. Quantitatively, this mRNA approximates the level of full-length
genomic RNA early in infection. The integrase (IN) domain of reverse
transcriptase does not contain the canonical HH-CC zinc finger motif
present in all characterized retroviral INs, but it does contain a
nearby histidine residue that could conceivably participate as a member
of the zinc finger. The env gene encodes a protein that is
over 40% identical in sequence to the HFV Env. By comparison, the Gag
precursor of BFV is predicted to be only 28% identical to the HFV
protein.
 |
INTRODUCTION |
Spumaviruses (foamy viruses) were
first described in 1954 by Enders and Peebles as cytopathogenic agents
of primary monkey kidney cells (7). Since that time, these
viruses have been isolated from other species including humans,
felines, and bovines (12, 23, 27). Based on serology, foamy
virus infections appear to be quite common in monkeys (simian foamy
viruses [SFVs]) and cattle (bovine foamy viruses [BFVs]) (1,
2, 24, 31). Despite their early identification and widespread
presence, the foamy viruses remain the least well characterized among
the retroviruses, probably because they have not been associated with
disease. It is interesting that while these viruses cause a pronounced
cytopathic effect in a wide variety of tissue culture cells, they
appear to be benign in vivo. This lack of apparent pathogenicity has led to the idea that the foamy viruses may be suitable delivery vectors
for gene therapy (40, 43). However, it has been suggested that their presence in the host may contribute to diseases caused by
other pathogens (25). Also, transgenic mice expressing human foamy virus (HFV) proteins have been reported to present a progressive encephalopathy and myopathy, suggesting that foamy viruses have pathogenic potential (5, 45).
The HFV and isolates of SFV type 1 (SFV-1) and SFV-3 have been
molecularly cloned, sequenced, and characterized previously (9,
12, 17, 26, 35). The most prominent structural feature of these
viruses is the presence of two accessory genes, one of which
(bel1 or taf) encodes a transcriptional
transactivator (19, 34). The primate foamy viruses are
unique in their lack of Cys-His motifs in the nucleocapsid (NC) domain
of the Gag protein and the major homology region in the capsid (CA)
domain of Gag. The foamy viruses contain an internal promoter that
directs transcription of their 3' accessory genes early in infection
(6, 20-22, 29, 34). Further, the Pol polyprotein in primate
foamy viruses is synthesized from a spliced mRNA, rather than by
frameshifting or termination suppression mechanisms (4, 8, 14,
46). Finally, in contrast to the other retroviruses, cells
infected with HFV produce a large proportion of virions that contain
genomic-length DNA. These several properties suggest that the foamy
viruses may be related to the pararetroviruses and hepadnaviruses
(39, 46).
The relationship of primate foamy viruses and nonprimate foamy viruses
has not been clearly established. To determine if the unique aspects
reported for the primate foamy viruses represent general hallmarks of
foamy viruses, we have extended the reported sequence analysis of the
long terminal repeat (LTR) and 3' portion of BFV (36-38) to
include the entire genome of an infectious DNA clone. In addition, we
have carried out experiments to measure the levels of spliced
pol mRNA. The results imply that BFV is similar in all
respects to the primate foamy viruses, sharing with them an internal
promoter in env, a spliced pol mRNA, and an NC
protein that contains Gly-Arg-rich motifs rather than Cys-His motifs.
The levels of BFV spliced pol mRNA, which has not been quantitated in other foamy virus studies, are notably high.
Surprisingly, the predicted Env proteins of the foamy viruses are
considerably more closely related to each other than to the Gag
proteins, suggesting that different foamy viruses may use a highly
conserved receptor.
 |
MATERIALS AND METHODS |
DNA sequencing.
The sequence of the BFV genome was
determined from p11-1 and p11-10 subclones derived from the infectious
bovine syncytial virus type 11 (BSV-11)
clone (38).
Plasmids were prepared by alkaline minipreparation and were manually
sequenced with Sequenase (U.S. Biochemical). Sequence data from small
random subclones was derived from BSV-11 by shearing to approximately
250 bp or obtained by processively walking through p11-1 and p11-10
with sequence-specific primers. The BFV genome was assembled with
AssemblyLIGN and analyzed with MacVector, DNAStar, and the Wisconsin
Genetics Computer Group package. The EcoRI junction point of
subclones 11-1 and 11-10 was sequenced from a PCR-generated clone that
spanned the internal EcoRI site of BSV-11. Additionally, the
PCR products spanning the gag-pol junction of six
independent isolates obtained from the Cornell Veterinary School
Diagnostic Laboratory were sequenced. Isolate 489770 was collected in
Vermont in 1989, 422809 was from Ohio in 1988, 792152 was collected in
New York in 1994, 336848 was collected in New York in 1987, 334862 was
collected also in New York in 1987, and 438340 was collected in
Connecticut in 1988.
Identification of a spliced pol mRNA.
Total RNA
was isolated from Cf2Th (ATCC CRL-1430) tissue culture cells
productively infected with BSV with the Genosys RNA isolation kit. The
RNA was reverse transcribed with random hexamers and murine leukemia
virus reverse transcriptase (RT) (New England Biolabs) according to the
manufacturer's specifications. The cDNA from these reactions was
amplified with a forward primer from nucleotides (nt) 20 to 39 that
contained an added KpnI site and two reverse primers at
positions 2120 to 2145 and 2420 to 2445. The PCR products were gel
purified with a Qiagen kit; cut with KpnI and
NaeI, which occurs at position 2020; and cloned into pBluescriptSK
cut with KpnI and
EcoRV. These products were sequenced as described above.
Relative quantitation of the spliced pol
transcript.
Total RNA was isolated from Cf2Th cells and
BFV-infected cells as described above. BFV-infected Cf2Th cells, ca.
80% confluent with approximately 10% of the cells displaying
syncytia, were trypsinized and seeded at a 1:10 dilution onto
uninfected Cf2Th cells (100-mm plates) that had been trypsinized and
seeded (1:10) the previous day. At 2, 3, and 4 days postinoculation,
total RNA was isolated from three separate plates for a total of nine
samples. RNAs were isolated from three uninfected Cf2Th cultures to
serve as controls. All RNA samples were treated for 4 h at 37°C
with RNase-free DNase (Boehringer) in reverse transcription buffer, followed by phenol-chloroform extraction and ethanol precipitation. The
samples were dissolved in 25 µl of water, and 0.5 µg was used in a
25-µl reverse transcription reaction as described above. The
resultant cDNAs were diluted to 50 µl with water and used as
templates for competitive PCR.
Competitive PCR.
The PCR strategy using mutant competitors
of the same size as the amplification products produced from native
mRNAs has been described elsewhere (28). Briefly,
competitors for specific transcripts were generated by PCR with one
primer approximately 45 bases in length that spans a restriction site.
This primer is used to incorporate an alternative restriction site in
the same position as the restriction site in the native sequence. To
quantitate the amount of the spliced pol mRNA, the primers homologous to nt 52 to 91 and 1941 to 1960 were used to amplify a
175-bp competitor from a plasmid clone that has a BamHI site substituted for the BglII site at nt 80 to 85. Competitors
for transcripts containing gag sequences and
Borf-2 sequences were similarly synthesized with primers
homologous to nt 588 to 630 and 751 to 770 (gag) and 9573 to
9592 and 9711 to 9753 (Borf-2). The gag
competitor has a BglII site substituted for the
BamHI site at nt 619 to 624; the Borf-2
competitor also has a BglII site substituted for the
BamHI site at nt 9717 to 9722. Following amplification of
the respective competitors, each was purified from an agarose gel
(Qiagen kit) and quantitated spectrophotometrically. Experimentally, a
dilution series of each competitor was used in PCRs containing 1 µl
of the reverse transcription reaction mixtures described above. One
sample from each RNA time point was processed in triplicate with each
competitor series to determine the reproducibility of the PCRs. In
addition, all samples were run individually to control for variability
at the level of RNA isolated at different time points and the
efficiency of cDNA synthesis. A cocktail containing buffer,
Mg2+, deoxynucleoside triphosphates, and primers was
dispensed, and the cDNA and competitors were added. The primer pairs
used in these amplifications were homologous to nt 52 to 71 and 1941 to 1960 (pol), 588 to 607 and 751 to 770 (gag), and
9573 to 9592 and 9734 to 9711 (Borf-2). The samples were
heated at 96°C for 5 min and immediately cooled in ice, and
Taq polymerase was added. The samples were amplified for 35 cycles of 94°C for 30 s, 50°C for 30 s, and 72°C for
40 s, followed by a 72°C extension for 10 min. Five microliters
from each sample was digested with BamHI or BglII
to analyze whether the PCR product was made predominantly from the
competitor or from native cDNA. When the levels of digestion products
generated from the competitor and native cDNA were equal, as seen by
ethidium bromide staining, the amount of viral mRNA from the infected
cells above was inferred. These results are not quantitative in an
absolute sense, but relative amounts of specific mRNAs can be deduced.
Nucleotide sequence accession number.
The sequence of the
BFV proviral genome has been deposited in the GenBank database
(accession no. U94514).
 |
RESULTS |
The genomic organization of the BFV provirus is shown in Fig.
1. The sequences of the BFV LTR,
Borf-1, and Borf-2 have been reported elsewhere
(36, 37). The results reported here use the putative
transcriptional start at nt 982 in the BFV LTR (36) as
position 1.

View larger version (7K):
[in this window]
[in a new window]
|
FIG. 1.
Genomic organization of BFV. The open reading frames for
BFV were determined from the DNA sequence of BSV-11 described by
Renshaw et al. (38). The approximate positions of the viral
splice donor (SD), splice acceptor site for pol mRNA (SA),
the Gly-Arg-rich region in Gag (GR), and the internal promoter (IP) are
shown.
|
|
gag gene.
The Gag polyproteins of primate foamy
viruses range in size from 646 amino acid (aa) residues in SFV-3 to 673 aa residues in SFVcpz (19). The sequence of BFV type 11 (BFV-11) shows that the gag open reading frame (nt 433 to
2064) encodes a Gag polyprotein of 544 aa residues. Protein alignments
with the DNAStar package showed that the BFV Gag polyprotein has no
amino acid sequence similarity with retroviruses outside the
Spumavirinae and only limited identity with the primate Gag
proteins, i.e., 24% identity with SFV-3 and 29% identity with SFV-1
(Table 1). Despite the primary sequence
divergence among the foamy virus Gag proteins, their hydrophilicity
profiles are quite similar and each has a hydrophilic C terminus (data
not shown). The proteolytic products of foamy virus Gag polyproteins
have not been purified and thus are not clearly defined. While there is
no evidence that the spumavirus Gag polyprotein is cleaved during a
budding-associated maturation process, as seen with other retroviruses,
putative cleavage has been identified in lysates of HFV-infected BHK-21
cells by Western blot analysis (30). Recently, it was
reported that the HFV Gag polyprotein is cleaved early after infection,
producing a matrix (MA) protein of 26 kDa, a CA protein of 32 kDa, and
an NC protein of 18 kDa (10). The BFV Gag polypeptide has a
very proline-rich segment of approximately 48 residues starting at aa
157 that is reminiscent of the segment seen between MA and CA in other
retroviruses, e.g., the murine leukemia virus and the avian sarcoma and
leukosis viruses. By analogy with other Gag polyproteins, the BFV MA
protein is likely encoded at the amino-terminal end of Gag and is
comprised of approximately 155 to 200 aa residues. Starting at ca.
position 200 in the predicted BFV Gag protein is a region of amino acid conservation that aligns with ca. position 300 to about 320 in the
primate Gag proteins. We suggest that this is a region within CA and
that the difference in overall lengths of the BFV and primate gag-encoded proteins is in the region connecting MA and CA,
as is found in other retroviruses.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Similarities of proteins predicted from the major open
reading frames of BFV with those predicted from the sequences of
the primate viruses
|
|
The NC proteins of the spumaviruses do not contain the zinc finger
domain(s) of other retroviruses (reviewed in reference 18). They do, however, contain three
glycine-arginine-rich regions (GR boxes 1, 2, and 3) that are
postulated to bind genomic RNA during virion assembly and have recently
been shown to direct transport of the HFV Gag precursor to the nuclei
of infected cells (42). While there is no discernible amino
acid sequence conservation of GR box 1 among any of the spumaviruses,
within the 23-aa GR box 2, which is necessary for transport of Gag to
the nucleus, there are 10 conserved positions that possibly constitute
the functional core of this element (Fig.
2). Also, within the 34-aa stretch
identified as GR box 3 there is a region where six of eight amino acid
residues are identical to those in the primate spumavirus NC proteins.
There is no obvious similarity in the carboxy-terminal regions of the
spumavirus Gag proteins beyond GR box 3. As with the primate foamy
viruses, the BFV gag and pol open reading frames
are overlapping. We have confirmed this overlap by sequence analysis of
PCR products from six BFV samples from the Cornell Veterinary
Diagnostic Laboratory (data not shown).

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 2.
Alignment of glycine-arginine-rich regions (GR boxes 1 to 3) within the putative NC proteins of spumaviruses (38).
Amino acid residues that are conserved in the foamy virus NC proteins
are in boldface and underlined. The amino acid positions of the GR
boxes within the respective Gag polyproteins flank the amino acid
sequences.
|
|
pro and pol genes.
As in the genomes
of the primate spumaviruses, the pro and pol
genes of BFV are contiguous in the same open reading frame. In contrast
to the other retroviruses that translate pol from full-length mRNA as part of a gag-pol polyprotein, it has
been shown that the primate spumaviruses express pol gene
products from a spliced mRNA (14, 46). Recently, it has also
been reported that the feline foamy virus produces a spliced
pol mRNA (4). BFV sequence similarity with the
HFV splice donor and splice acceptor sites allowed us to design PCR
primers that amplify across the putative pol mRNA splice
junction. Figure 3 shows the splice
junction of the pol mRNA obtained by RT-PCR. The junction is
from nt 51 in the BFV leader sequence to nt 1776 in the BFV genome.
Like that in the primate foamy viruses, the BFV pol mRNA is
predicted to contain a long untranslated region, in this case one of
242 nt, prior to the first ATG codon of the pol open reading
frame at nt 2018. We suggest that the translation of the pol
open reading frame is likely to begin at this ATG codon, which encodes
the first amino acid of protease. We were led to this conclusion based on the observation that the conserved PR sequence DSGA begins at aa 21, similar to the position (aa 25) of the DTGA sequence in the mature
human immunodeficiency virus PR (33). The mature PR of
primate spumaviruses is approximately 10 kDa, but the size of the BFV
PR is yet to be determined. Within RT, the first recognizable motif is
ENQV. By analogy with the other retroviral Pol proteins, we estimate
that the amino terminus of RT is approximately 40 residues upstream of
this sequence, consistent with a PR comprising approximately 100 aa
residues.

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 3.
Alignment of the pol mRNA splice junctions of
BFV, HFV, and feline foamy virus (FeFV). Conserved nucleotides are
shown in boldface. The nucleotide positions of the BFV splice donor and
acceptor are shown above the sequence.
|
|
The BFV pol gene encodes amino acid sequences typically seen
in other retroviral enzymes. Since the amino terminus of RT is not
known, we used the N-terminal methionine of PR as the reference for
numbering residues of RT and integrase (IN). The BFV pol
gene encodes the RT signature sequence YVDD at aa 309 to 312. Other conserved RT motifs that can be aligned with known retroviral RTs are
found at aa 248 to 250 (LDL) and 281 to 284 (LPQG). The conserved
sequences TDSY and TDS at positions 368 to 371 and 667 to 669, respectively, identify the RNase H domain of RT. Motifs typical of IN
are seen at aa 885 to 888 (DYIG) and 991 to 994 (SDQG). Interestingly,
the proline residue at position 819 disrupts the canonical HH-CC zinc
finger motif present in all characterized retroviral INs (15,
32). Provocatively, the histidine residue at position 816 in BFV
is not present in any other spumaviruses, suggesting the possibility
that it may participate as a member of the Zn2+ finger.
Alternatively, the subclone of BSV-11, used for the sequencing, has had
a single base change, CAC to CCC, resulting in the substitution of Pro
for His, which could result in an inactive virus. This seems unlikely,
however, because the BSV-11 clone has been shown elsewhere to be
infectious (38) and the sequences of the PCR products
derived from two independent infectious isolates (489770 and 422809)
also encode His and Pro at positions 816 and 819, respectively.
env gene.
The predicted BFV Env protein is 990 aa
in length, which is comparable to the primate foamy virus Env proteins,
which are 984 (SFV-1) to 1020 (SFVcpz) aa in length. Interestingly,
alignment of the foamy virus Env proteins does not identify
hypervariable regions that are typical of many retroviral Env proteins
but rather a nearly uniform distribution of conserved amino acids (Fig.
4). This data suggests that the Env
proteins of foamy viruses from genetically distant hosts may be
functionally conserved. The amino acid identity of the BFV Env with
members of this group ranges from 32.9% (SFV-3) to 41.3% (HFV) (Table
1). A putative hydrophobic leader peptide can be identified from aa 54 to 89. The sequence KRTRR is present in Env starting at aa position
568. This sequence is analogous to the SFV and HFV Env protein
sequences suggested to be the recognition sequences for proteolysis
leading to the production of SU and TM (19). Consistent with
this hypothesis is the presence of 11 potential N-linked glycosylation
sites in the putative BFV SU. Assuming that KRTRR is the SU-TM cleavage site, there is 25% amino acid sequence identity in SU among all the
foamy virus isolates. The smaller TM has approximately 38% amino acid
sequence identity with each of the foamy virus isolate TM proteins. The
sequence xxGxxxxxAxxTLSxxS occurs near the amino terminus of TM. This
sequence is conserved among the foamy viruses and is thought to be
important for membrane fusion. Near the carboxy terminus of the BFV TM
is a hydrophobic region that aligns with an analogous region in the
other primate foamy viruses and probably represents the membrane anchor
domain of TM. This domain is followed by a very short (11 aa in BFV),
highly basic region that forms the cytoplasmic tail of TM. It has been
suggested that this highly basic tail may be important to the
interactions of TM with the gag-derived MA protein during
virus assembly (19). The TM proteins of the primate foamy
viruses have lysine residues at positions
5 and
3 from their
respective carboxy termini (11). This motif is an
endoplasmic retrieval signal. The BFV TM differs by having an Arg at
position
5 from the carboxy terminus. It was previously suggested
that the Arg residues at
4,
5, and
6 may compensate for the lack
of a lysine at position
5 (13).

View larger version (58K):
[in this window]
[in a new window]
|
FIG. 4.
Alignment of foamy virus Env proteins. Identical amino
acids conserved among the foamy viruses are shown in bold. Putative
functional domains are shown; the putative leader peptide is underlined
with dashes, the proposed SU-TM cleavage site is marked by asterisks,
the cell fusion domain is marked by number signs, the transmembrane
segment is marked by plus signs, and the basic cytoplasmic tail is
marked by carets. The amino acid positions of the Env proteins are to
the right of the sequences.
|
|
Previously, an internal promoter in the primate foamy virus
env gene that directs early transcription of the 3' open
reading frames was identified (6, 20-22, 29, 34). An
analogous promoter region in BFV is apparent by sequence comparison
with HFV and SFV-1 (Fig. 5). A DNA
fragment containing the putative BFV internal promoter actively directs
the transcription of Borf-1 in transient transfection
experiments (9a).

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 5.
Alignment of foamy virus internal promoters. The
nucleotide position of the first base from the start of transcription
is shown on the right. Conserved nucleotides are in boldface. The TATA
box and the starts of HFV ( ) and SFV-1 ( ) transcription are
underlined, as is the putative transcription start in BFV.
|
|
Relative levels of BFV spliced pol mRNA,
gag mRNA, and Borf-2 mRNA.
Recent
experiments have indicated that low levels of spliced pol
mRNA are produced during HFV infection, but the actual amount of this
mRNA species was not quantified (46). Our initial
experiments showed that BFV produced a spliced pol mRNA that
appeared to be relatively abundant. We undertook a series of
quantitative-competitive RT-PCR experiments to estimate the relative
amount of BFV spliced pol mRNA relative to other viral
transcripts. The experiments were designed to amplify cDNA that is
unique to the spliced pol mRNA (spanning the splice
junction) and to compare its level to that of viral RNAs that contain
gag and Borf-2 sequences. For these experiments,
total RNA was isolated from BFV-infected Cf2Th cells and quantitated.
cDNA was made from the RNA by using random hexamers as primers and used
as the template for competitive PCR. The competitors for each of these
mRNAs were quantitated and mixed in different amounts with the cDNAs
derived from viral RNA in PCRs. The relative amounts of PCR product
derived from the competitor and from cDNA can be distinguished by
digestion with BamHI or BglII followed by agarose
gel electrophoresis. When the PCR products derived from the cDNA and
competitor are equal, the amount of cDNA equals the amount of
competitor.
A segment near the 3' end of the BFV genome (within Borf-2),
which is presumably present in all viral mRNAs, was also amplified as
an additional measurement of viral RNA levels. No amplification products were observed with RNA from uninfected cells or with RNA from
infected cells when the reverse transcription step was omitted. Typical
results from these experiments are shown in Fig. 6. The approximate amounts of spliced
pol mRNA, gag-containing viral RNA, and viral RNA
representing a region in Borf-2 are ca. 20 to 40, ca. 40 to
80, and ca. 80 to 100 fg, respectively. These results were
reproducible, within a factor of 2, for RNAs from the same sample and
among samples independently collected at the same time point. The
amount of viral RNAs approximately doubled from day 2 to day 4 (data
not shown). Since the Borf-2 sequence is present in all RNA
species initiated from the LTR and the internal promoter, the expected
amount of the Borf-2 mRNA should be greater than the sum of
the gag and spliced pol mRNAs. The contribution of the internal promoter to the level of Borf-2 mRNA is
unknown, and the confidence level of these experiments is approximately a factor of 2. The result that Borf-2 mRNA abundance was at
least the sum of gag and pol mRNAs thus is
consistent with our expectation and implies that the internal promoter
contributed no more than 50% of the transcripts containing the 3' end
of the virus in these experiments. In summary, these results show that
the splicing event that leads to BFV pol mRNA is not rare,
with the ratio of BFV spliced pol mRNA to
gag-containing mRNA being within the range of 1:1 to 1:4.

View larger version (52K):
[in this window]
[in a new window]
|
FIG. 6.
Competitive PCR determination of the levels of
gag, spliced pol, and Borf-2 specific
mRNAs from cells collected after 4 days of cocultivation. The amount of
specific competitor DNA added to each PCR is shown above appropriate
gel lanes. Lanes C show the no-DNA-added PCR control. Five microliters
of each PCR was cut in 20 µl with either BamHI (B) or
BglII (G) and run on a 3% agarose gel for analysis. (A)
Spliced pol mRNA; (B) gag mRNA; (C)
Borf-2 mRNA.
|
|
 |
DISCUSSION |
We have shown that BFV has a genomic organization very similar to
that of the primate foamy viruses, which themselves are closely related
to each other. This similarity extends beyond gag,
pol, and env genes to the two 3' accessory genes,
Borf-1 and Borf-2. While Borf-1 and
Borf-2 do not show sequence similarity with their
counterparts, Borf-1 encodes a transactivator of
transcription from the 5' LTR, like its analogous gene in the primate
viruses. As expected, the RT-encoding region in pol is the
most highly conserved sequence in BFV and clearly places this bovine
virus in the foamy virus genus (Fig. 7).
Among the group of foamy viruses, HFV and SFV-1 exhibit the greatest
similarity to BFV, not only in RT but in gag and
env as well (Table 1).

View larger version (10K):
[in this window]
[in a new window]
|
FIG. 7.
Phylogenetic tree. Amino acid sequences representing
segments of IN (44) were analyzed with software from DNAStar
(41).
|
|
The replication and gene expression of foamy viruses, as documented in
HFV and SFV-1 and, in some respects, in SFV-3, distinguish them from
all other retroviruses. We have shown that BFV also shares several of
these features. The sequence of BFV shows a putative internal promoter
in env, and plasmids containing this region transactivate
the LTR in transfection studies (data not shown). A spliced RNA capable
of directing the synthesis of the Pol polyprotein is present in
infected cells, and the splice-junction sequence is very similar to
those reported for HFV and feline foamy virus (4, 46). The
HFV pol mRNA was reported to be of low abundance, an
observation that is consistent with a splicing mechanism that regulates
the amount of Pol. We have carried out quantitative determinations of
the BFV pol mRNA and found it to be present at high levels,
approaching the level of viral RNA. These determinations were made
early in infection, because spumavirus virions are not efficiently
released; they accumulate in cells and could skew the ratio of spliced
versus unspliced viral RNA in the analysis. The abundance of BFV
pol mRNA suggests that if the ratio of Gag to Pol seen in
other retroviruses (20:1), due to translational suppression or
translational frameshifting, is present in BFV, it is not regulated by
the relative amounts of their respective mRNAs. Thus, splicing does not
appear to be a limiting step in the production of Pol. The BFV
initiator codon for Pol translation is in a reasonable context
(16) with an A residue at
3 and C residues at
4,
6,
and
7. Perhaps the pol leader exerts a negative influence
on translation, or perhaps the BFV Pol protein is more abundant than in
other retrovirus systems.
The protein products of the primate foamy viruses and BFV have not been
extensively characterized from cells or virus particles. We have
identified the domains of Gag that likely encompass the mature MA, CA,
and NC of BFV, based on analogy with data in reports describing HFV
proteins (3, 10, 30). One clearly conserved region within
the BFV gag gene encodes the GR boxes of the putative NC
protein. The GR motifs have been postulated to bind genomic RNA during
virion assembly and to direct transport of HFV Gag to the nucleus
(42). While nuclear localization of Gag in primate foamy
viruses is unique among retroviruses, its purpose is unclear. Based on
immunofluorescence, BFV Gag is also likely to be targeted to the
nucleus (24). The amino acid positions in the GR boxes that
are conserved among all the foamy viruses may define the functional
cores of these motifs. Interestingly, while the GR boxes are conserved
in the foamy viruses, the GRII motif is dispensable for viral
replication in vitro (47).
The extent of amino acid conservation in the Env protein of primate
foamy viruses compared with that in BFV is striking. For example, in
most retroviruses, Env is less conserved than is Gag, the opposite of
our findings for BFV and the primate foamy viruses. Bovine leukemia
virus and human T-cell leukemia virus type 1 Gag and Env proteins are
ca. 35 and 20% identical, respectively. It seems rather remarkable
that over 40% of the amino acid residues are identical in the BFV and
HFV Env proteins (Fig. 4). One possible interpretation of this
similarity is that foamy viruses bind to the same receptor and that
this receptor itself is highly conserved among animal species. The use
of a common receptor may have implications for the development of foamy
viruses as vectors in gene therapy. It has been established that foamy
viruses can infect a wide variety of cultured cells. Identification and
characterization of the primate foamy virus and BFV receptors and
studies of host range and tissue tropism of these viruses are important
preliminaries to the development of these viruses as vectors for gene
delivery.
The biology of foamy viruses in vivo is relatively unknown and merits
investigation. With the reagents that have recently been developed, the
mechanisms of foamy virus latency, persistence, and possible
pathogenesis can be examined.
 |
ACKNOWLEDGMENTS |
We thank Volker Vogt for his advice and reading of the
manuscript. We also thank Martin Lochelt and Rolf Flugel for providing us with the sequence of HFV prior to its being deposited in GenBank (accession no. U21247).
This work was supported in part with funds from CSREES USDA under
project no. 433381 (D.L.H.) and with a grant from the Harold Wetterberg
Foundation (J.W.C.).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853. Phone: (607) 253-3579. Fax: (607) 253-3384. E-mail: JWC3{at}cornell.edu.
Present address: Department of Biology, Ohio University, Athens, OH
45701.
 |
REFERENCES |
| 1.
|
Amborski, G. F.,
J. L. Lo, and C. L. Seger.
1989.
Serological detection of multiple retroviral infections in cattle: bovine leukemia virus, bovine syncytial virus, and bovine visna virus.
Vet. Microbiol.
20:247-253[Medline].
|
| 2.
|
Appleby, R. C.
1979.
Antibodies to bovine syncytial virus in dairy cattle.
Vet. Rec.
105:80-81[Medline].
|
| 3.
|
Bartholoma, A.,
W. Muranyi, and R. M. Flugel.
1992.
Bacterial expression of the capsid antigen domain and identification of native gag proteins in spumavirus-infected cells.
Virus Res.
23:27-38[Medline].
|
| 4.
|
Bodem, J.,
M. Löchelt,
I. Winkler,
R. P. Flower,
H. Delius, and R. M. Flügel.
1996.
Characterization of the spliced pol transcript of feline foamy virus: the splice acceptor site of the pol transcript is located in gag of foamy viruses.
J. Virol.
70:9024-9027[Abstract].
|
| 5.
|
Bothe, K.,
A. Aguzzi,
H. Lassmann,
A. Rethwilm, and I. Horak.
1991.
Progressive encephalopathy and myopathy in transgenic mice expressing human foamy virus genes.
Science
253:555-557[Abstract/Free Full Text].
|
| 6.
|
Campbell, M.,
L. Renshaw-Gegg,
R. Renne, and P. A. Luciw.
1994.
Characterization of the internal promoter of simian foamy viruses.
J. Virol.
68:4811-4820[Abstract/Free Full Text].
|
| 7.
|
Enders, J. F., and T. C. Peebles.
1954.
Propagation in tissue cultures of cytopathogenic agents from patients with measles.
Proc. Soc. Exp. Biol. Med.
86:277-286.
|
| 8.
|
Enssle, J.,
I. Jordan,
B. Maurer, and A. Rethwilm.
1996.
Foamy virus reverse transcriptase is expressed independently from the Gag protein.
Proc. Natl. Acad. Sci. USA
93:4137-4141[Abstract/Free Full Text].
|
| 9.
|
Flugel, R. M.,
A. Rethwilm,
B. Maurer, and G. Darai.
1987.
Nucleotide sequence analysis of the env gene and its flanking regions of the human spumaretrovirus reveals two novel genes.
EMBO J.
6:2077-2084[Medline].
|
| 9a.
| Garnica, J., and D. Holzschu. Unpublished data.
|
| 10.
|
Giron, M.-L.,
S. Colas,
J. Wybier,
F. Rozain, and R. Emanoil-Ravier.
1997.
Expression and maturation of human foamy virus Gag precursor polypeptides.
J. Virol.
71:1635-1639[Abstract].
|
| 11.
|
Goepfert, P. A.,
G. Wang, and M. J. Mulligan.
1995.
Identification of an ER retrieval signal in a retroviral glycoprotein.
Cell
82:543-544[Medline].
|
| 12.
|
Herchenroder, O.,
R. Renne,
D. Loncar,
E. K. Cobb,
K. K. Murthy,
J. Schneider,
A. Mergia, and P. A. Luciw.
1994.
Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (SFVcpz): high homology to human foamy virus (HFV).
Virology
201:187-199[Medline].
|
| 13.
|
Jackson, M. R.,
T. Nilsson, and P. A. Peterson.
1990.
Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum.
EMBO J.
9:3153-3161[Medline].
|
| 14.
|
Jorden, I.,
J. Enssle,
E. Guettler,
B. Mauer, and A. Rethwilm.
1996.
Expression of human foamy virus reverse transcriptase involves a spliced pol mRNA.
Virology
224:314-319[Medline].
|
| 15.
|
Khan, E.,
J. P. G. Mack,
R. A. Katz,
J. Kulkosky, and A. M. Skalka.
1990.
Retroviral integrase domains: DNA binding and the recognition of LTR sequences.
Nucleic Acids Res.
19:851-860[Abstract/Free Full Text].
|
| 16.
|
Kozak, M.
1987.
An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs.
Nucleic Acids Res.
15:8125-8148[Abstract/Free Full Text].
|
| 17.
|
Kupiec, J. J.,
A. Kay,
M. Hayat,
R. Ravier,
J. Peries, and F. Galibert.
1991.
Sequence analysis of the simian foamy virus type 1 genome.
Gene
101:185-194[Medline].
|
| 18.
|
Linial, M. L., and A. D. Miller.
1990.
Retroviral RNA packaging: sequence requirements and implications.
Curr. Top. Microbiol. Immunol.
157:125-152[Medline].
|
| 19.
|
Lochelt, M., and R. M. Fluegel.
1995.
The molecular biology of human and primate spuma retroviruses, p. 239-292. In
J. A. Levy (ed.), The Retroviridae, vol. 4.
Plenum Press, New York, N.Y.
|
| 20.
|
Löchelt, M.,
R. M. Flügel, and M. Aboud.
1994.
The human foamy virus internal promoter directs the expression of the functional Bel 1 transactivator and Bet protein early after infection.
J. Virol.
68:638-645[Abstract/Free Full Text].
|
| 21.
|
Lochelt, M.,
W. Muranyi, and R. M. Flugel.
1993.
Human foamy virus genome possesses an internal, Bel-1-dependent and functional promoter.
Proc. Natl. Acad. Sci. USA
90:7317-7321[Abstract/Free Full Text].
|
| 22.
|
Lochelt, M.,
S. F. Yu,
M. L. Linial, and R. M. Flugel.
1995.
The human foamy virus internal promoter is required for efficient gene expression and infectivity.
Virology
206:601-610[Medline].
|
| 23.
|
Loh, P. C.
1993.
Spumaviruses, p. 361-397. In
J. A. Levy (ed.), The Retroviridae, vol. 2.
Plenum Press, New York, N.Y.
|
| 24.
|
Malmquist, W. A.,
M. J. Van Der Maaten, and A. D. Boothe.
1969.
Isolation, immunodiffusion, immunofluorescence, and electron microscopy of a syncytial virus of lymphosarcomatous and apparently normal cattle.
Cancer Res.
29:188-200[Abstract/Free Full Text].
|
| 25.
|
Marino, S.,
C. Kretschmer,
S. Bradner,
C. Cavard,
A. Zider,
P. Briand,
S. Flsenmann,
E. F. Wagner, and A. Aguzzi.
1995.
Activation of HIV transcription by human foamy virus in transgenic mice.
Lab. Invest.
73:103-110[Medline].
|
| 26.
|
Maurer, B.,
H. Bannert,
G. Darai, and R. M. Flügel.
1988.
Analysis of the primary structure of the long terminal repeat and the gag and pol genes of the human spumaretrovirus.
J. Virol.
62:1590-1597[Abstract/Free Full Text].
|
| 27.
|
McClure, M. O.,
P. D. Bieniasz,
T. F. Schulz,
I. L. Chrystie,
G. Simpson,
A. Aguzzi,
J. G. Hoad,
A. Cunningham,
J. Kirkwood, and R. A. Weiss.
1994.
Isolation of a new foamy retrovirus from orangutans.
J. Virol.
68:7124-7130[Abstract/Free Full Text].
|
| 28.
|
McCulloch, R. K.,
C. S. Choong, and D. M. Hurley.
1995.
An evaluation of competitor type and size for use in the determination of mRNA by competitive PCR.
PCR Methods Appl.
4:219-226.
|
| 29.
|
Mergia, A.
1994.
Simian foamy virus type 1 contains a second promoter located at the 3' end of the env gene.
Virology
199:219-222[Medline].
|
| 30.
|
Netzer, K.,
A. Rethwilm,
B. Maurer, and V. ter Meulen.
1990.
Identification of the major immunogenic structural proteins of human foamy virus.
J. Gen. Virol.
71:1237-1241[Abstract/Free Full Text].
|
| 31.
|
Neumann-Haefelin, D.,
U. Fleps,
R. Renne, and M. Schweizer.
1993.
Foamy viruses.
Intervirology
35:196-207[Medline].
|
| 32.
|
Pahl, A., and R. M. Flugel.
1995.
Characterization of the human spuma retrovirus integrase by site-directed mutagenesis, by complementation analysis, and by swapping the zinc finger domain of HIV-1.
J. Biol. Chem.
270:2957-2966[Abstract/Free Full Text].
|
| 33.
|
Rao, J. K. M.,
J. W. Erickson, and A. Wlodawer.
1991.
Structural and evolutionary relationships between retroviral and eucaryotic aspartic proteinases.
Biochemistry
30:4663-4671[Medline].
|
| 34.
|
Renne, R.,
U. Fleps,
P. A. Luciw, and D. Neumann-Haefelin.
1996.
Transactivation of the two promoters of SFV-3 by different mechanisms.
Virology
221:362-367[Medline].
|
| 35.
|
Renne, R.,
E. Friedl,
M. Schweizer,
U. Fleps,
R. Turek, and D. Neumann-Haefelin.
1992.
Genomic organization and expression of simian foamy virus type 3 (SFV-3).
Virology
186:597-608[Medline].
|
| 36.
|
Renshaw, R. W., and J. W. Casey.
1994.
Analysis of the 5' long terminal repeat of bovine syncytial virus.
Gene
141:221-224[Medline].
|
| 37.
|
Renshaw, R. W., and J. W. Casey.
1994.
Transcriptional mapping of the 3' end of the bovine syncytial virus genome.
J. Virol.
68:1021-1028[Abstract/Free Full Text].
|
| 38.
|
Renshaw, R. W.,
M. A. Gonda, and J. W. Casey.
1991.
Structure and transcriptional status of bovine syncytial virus in cytopathic infections.
Gene
105:179-184[Medline].
|
| 39.
| Rethwilm, A. 1996. Unexpected replication pathways
of foamy viruses. J. Acquired Immune Defic. Syndr. Hum. Retrovirol.
13(Suppl. 1):S248-S253.
|
| 40.
|
Russell, D. W., and A. D. Miller.
1996.
Foamy virus vectors.
J. Virol.
70:217-222[Abstract].
|
| 41.
|
Saitou, N., and M. Nei.
1987.
The neighbor joining method: a new method of reconstructing phylogenetic trees.
Mol. Biol. Evol.
4:406-525[Abstract].
|
| 42.
|
Schliephake, A. W., and A. Rethwilm.
1994.
Nuclear localization of foamy virus Gag precursor protein.
J. Virol.
68:4946-4954[Abstract/Free Full Text].
|
| 43.
|
Schmidt, M., and A. Rethwilm.
1995.
Replicating foamy virus-based vectors directing high level expression of foreign genes.
Virology
210:167-178[Medline].
|
| 44.
|
Schweizer, M., and D. Neumann-Haefelin.
1995.
Phylogenetic analysis of primate foamy viruses by comparison of pol sequences.
Virology
207:577-582[Medline].
|
| 45.
|
Tschopp, R. R.,
S. Brandner,
S. Marino,
K. Bothe,
I. Horak,
A. Rethwilm, and A. Aguzzi.
1996.
Analysis of the determinants of neurotropism and neurotoxicity of HFV in transgenic mice.
Virology
216:338-346[Medline].
|
| 46.
|
Yu, S. F.,
D. N. Baldwin,
S. R. Gwynn,
S. Yendapalli, and M. L. Linial.
1996.
Human foamy virus replication: a pathway distinct from that of retroviruses and hepadnaviruses.
Science
271:1579-1582[Abstract].
|
| 47.
|
Yu, S. F.,
K. Edelmann,
R. K. Strong,
A. Moebes,
A. Rethwilm, and M. L. Linial.
1996.
The carboxy terminus of the human foamy virus Gag protein contains separable nucleic acid binding and nuclear transport domains.
J. Virol.
70:8255-8262[Abstract].
|
J Virol, March 1998, p. 2177-2182, Vol. 72, No. 3
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Bodem, J., Krausslich, H.-G., Rethwilm, A.
(2007). Acetylation of the foamy virus transactivator Tas by PCAF augments promoter-binding affinity and virus transcription. J. Gen. Virol.
88: 259-263
[Abstract]
[Full Text]
-
Eastman, S. W., Linial, M. L.
(2001). Identification of a Conserved Residue of Foamy Virus Gag Required for Intracellular Capsid Assembly. J. Virol.
75: 6857-6864
[Abstract]
[Full Text]
-
LaPierre, L. A., Holzschu, D. L., Bowser, P. R., Casey, J. W.
(1999). Sequence and Transcriptional Analyses of the Fish Retroviruses Walleye Epidermal Hyperplasia Virus Types 1 and 2: Evidence for a Gene Duplication. J. Virol.
73: 9393-9403
[Abstract]
[Full Text]
-
Linial, M. L.
(1999). Foamy Viruses Are Unconventional Retroviruses. J. Virol.
73: 1747-1755
[Full Text]
-
Yu, S. F., Sullivan, M. D., Linial, M. L.
(1999). Evidence that the Human Foamy Virus Genome Is DNA. J. Virol.
73: 1565-1572
[Abstract]
[Full Text]
-
Wang, G, Mulligan, M.
(1999). Comparative sequence analysis and predictions for the envelope glycoproteins of foamy viruses. J. Gen. Virol.
80: 245-254
[Abstract]